uniQure N.V. Company Profile (NASDAQ:QURE)

About uniQure N.V. (NASDAQ:QURE)

uniQure N.V. logoUniqure NV is a gene therapy company based in the Netherlands. The Company is engaged in the discovery, development and commercialization of single treatments with curative results for patients suffering from genetic and other severe diseases. The Company advances a focused pipeline of gene therapies that are developed both internally and through partnerships. The Company's product candidates within the Core Program include AMT-060 for Hemophilia B, AMT-130 for Huntington's disease and S100A1 for congestive heart failure. The Company, through its collaboration with Bristol Myers-Squibb (BMS), is focused on building a portfolio of gene therapies led by the S100A1 program for congestive heart failure.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Bio Therapeutic Drugs
  • Sub-Industry: N/A
  • Symbol: NASDAQ:QURE
  • CUSIP: N/A
  • Web: www.uniqure.com
Capitalization:
  • Market Cap: $492.54 million
  • Outstanding Shares: 25,560,000
Average Prices:
  • 50 Day Moving Avg: $9.85
  • 200 Day Moving Avg: $7.25
  • 52 Week Range: $4.72 - $19.34
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -7.33
  • P/E Growth: 0.00
Sales & Book Value:
  • Annual Revenue: $24.62 million
  • Price / Sales: 20.01
  • Book Value: $1.07 per share
  • Price / Book: 18.01
Profitability:
  • EBITDA: ($59,260,000.00)
  • Net Margins: -289.94%
  • Return on Equity: -131.27%
  • Return on Assets: -39.06%
Debt:
  • Debt-to-Equity Ratio: 0.59%
  • Current Ratio: 4.82%
  • Quick Ratio: 4.82%
Misc:
  • Average Volume: 431,086 shs.
  • Beta: 0.49
  • Short Ratio: 5.43
 

Frequently Asked Questions for uniQure N.V. (NASDAQ:QURE)

What is uniQure N.V.'s stock symbol?

uniQure N.V. trades on the NASDAQ under the ticker symbol "QURE."

How were uniQure N.V.'s earnings last quarter?

uniQure N.V. (NASDAQ:QURE) released its earnings results on Tuesday, August, 8th. The company reported ($0.83) EPS for the quarter, missing the consensus estimate of ($0.78) by $0.05. The firm earned $4.94 million during the quarter, compared to the consensus estimate of $2.92 million. uniQure N.V. had a negative net margin of 289.94% and a negative return on equity of 131.27%. View uniQure N.V.'s Earnings History.

When will uniQure N.V. make its next earnings announcement?

uniQure N.V. is scheduled to release their next quarterly earnings announcement on Tuesday, November, 28th 2017. View Earnings Estimates for uniQure N.V..

Where is uniQure N.V.'s stock going? Where will uniQure N.V.'s stock price be in 2017?

7 brokers have issued 12 month target prices for uniQure N.V.'s shares. Their predictions range from $8.00 to $19.00. On average, they expect uniQure N.V.'s share price to reach $14.40 in the next twelve months. View Analyst Ratings for uniQure N.V..

What are analysts saying about uniQure N.V. stock?

Here are some recent quotes from research analysts about uniQure N.V. stock:

  • 1. According to Zacks Investment Research, "UNIQURE B.V. is involved in developing gene therapy for patients of genetic or acquired diseases. It offers Glybera for the treatment of lipoprotein lipase deficiency, an orphan metabolic disease. The company's product pipeline includes which are in clinical trials are additional adeno-associated virus consist of AMT-060, AMT-021, AMT-110 and AAV2/glial. UNIQURE B.V. is headquartered in Amsterdam, the Netherlands. " (10/18/2017)
  • 2. Cowen and Company analysts commented, "QURE reported 1Q17 financials and presented multiple updates at ASGCT recently." (5/24/2017)

Who are some of uniQure N.V.'s key competitors?

How do I buy uniQure N.V. stock?

Shares of uniQure N.V. can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is uniQure N.V.'s stock price today?

One share of uniQure N.V. stock can currently be purchased for approximately $19.27.


MarketBeat Community Rating for uniQure N.V. (NASDAQ QURE)
Community Ranking:  3.8 out of 5 (star star star)
Outperform Votes:  340 (Vote Outperform)
Underperform Votes:  103 (Vote Underperform)
Total Votes:  443
MarketBeat's community ratings are surveys of what our community members think about uniQure N.V. and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for uniQure N.V. (NASDAQ:QURE) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 2 Hold Ratings, 5 Buy Ratings
Consensus Rating:Buy (Score: 2.71)
Consensus Price Target: $14.40 (25.27% downside)
Consensus Price Target History for uniQure N.V. (NASDAQ:QURE)
Price Target History for uniQure N.V. (NASDAQ:QURE)
Analysts' Ratings History for uniQure N.V. (NASDAQ:QURE)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/20/2017Leerink SwannBoost Price TargetOutperform -> Outperform$17.00 -> $19.00N/AView Rating Details
7/23/2017Chardan CapitalSet Price TargetBuy$13.00HighView Rating Details
6/30/2017Oppenheimer Holdings, Inc.Reiterated RatingOutperform$17.00LowView Rating Details
5/24/2017Cowen and CompanyReiterated RatingBuyMediumView Rating Details
4/12/2017Jefferies Group LLCReiterated RatingHold$8.00LowView Rating Details
12/6/2016WallachBeth CapitalLower Price TargetBuy$27.00 -> $15.00N/AView Rating Details
11/15/2016Piper Jaffray CompaniesDowngradeOverweight -> NeutralN/AView Rating Details
8/4/2016HC WainwrightInitiated CoverageBuy$21.00N/AView Rating Details
1/8/2016Janney Montgomery ScottReiterated RatingBuyN/AView Rating Details
1/8/2016Roth CapitalReiterated RatingBuy$37.00N/AView Rating Details
(Data available from 10/22/2015 forward)

Earnings

Earnings History for uniQure N.V. (NASDAQ:QURE)
Earnings by Quarter for uniQure N.V. (NASDAQ:QURE)
Earnings History by Quarter for uniQure N.V. (NASDAQ QURE)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/28/2017        
8/8/20176/30/2017($0.78)($0.83)$2.92 million$4.94 millionViewN/AView Earnings Details
5/9/20173/31/2017($0.64)($0.80)$4.20 million$3.32 millionViewN/AView Earnings Details
5/31/2016Q1($0.82)($0.93)$2.94 million$4.30 millionViewN/AView Earnings Details
4/4/2016Q415($0.60)($0.58)$2.78 million$6.78 millionViewN/AView Earnings Details
11/30/2015Q315($0.64)($1.14)$7.76 million$3.50 millionViewListenView Earnings Details
8/27/2015Q215($0.56)($0.98)$31.18 million$1.79 millionViewN/AView Earnings Details
6/11/2015Q1($0.82)($0.69)$9.50 million$1.17 millionViewN/AView Earnings Details
4/6/2015($0.62)($0.77)$1.38 million$1.61 millionViewN/AView Earnings Details
12/1/2014($0.53)($0.61)$2.00 million$1.30 millionViewN/AView Earnings Details
9/2/2014Q214($0.55)($1.35)$1.40 million$1.37 millionViewN/AView Earnings Details
6/6/2014($0.45)($0.52)$0.84 million$1.59 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for uniQure N.V. (NASDAQ:QURE)
2017 EPS Consensus Estimate: ($3.04)
2018 EPS Consensus Estimate: ($2.90)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20171($0.71)($0.71)($0.71)
Q2 20172($0.81)($0.71)($0.76)
Q3 20172($0.85)($0.84)($0.85)
Q4 20172($0.86)($0.58)($0.72)
Q1 20181($0.81)($0.81)($0.81)
Q2 20181($0.80)($0.80)($0.80)
Q3 20181($0.81)($0.81)($0.81)
Q4 20181($0.48)($0.48)($0.48)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for uniQure N.V. (NASDAQ:QURE)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for uniQure N.V. (NASDAQ:QURE)
Insider Ownership Percentage: 0.73%
Institutional Ownership Percentage: 29.86%
Insider Trades by Quarter for uniQure N.V. (NASDAQ:QURE)
Institutional Ownership by Quarter for uniQure N.V. (NASDAQ:QURE)
Insider Trades by Quarter for uniQure N.V. (NASDAQ:QURE)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/29/2017Harald PetryInsiderSell49,300$6.02$296,786.00View SEC Filing  
6/27/2017Harald PetryInsiderSell65,930$6.01$396,239.30View SEC Filing  
6/26/2017Harald PetryInsiderSell58,075$6.01$349,030.75View SEC Filing  
6/22/2017Harald PetryInsiderSell155$6.00$930.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for uniQure N.V. (NASDAQ:QURE)
Latest Headlines for uniQure N.V. (NASDAQ:QURE)
Source:
Loading headlines, please wait.

Social

Chart

uniQure N.V. (QURE) Chart for Sunday, October, 22, 2017

This page was last updated on 10/22/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.